These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35110451)

  • 1. [Boronic Acid as a Promising Class of Chemical Entity for Development of Clinical Medicine for Targeted Therapy of Cancer].
    Watanabe T; Momose I
    Yakugaku Zasshi; 2022; 142(2):145-153. PubMed ID: 35110451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merging the Versatile Functionalities of Boronic Acid with Peptides.
    Tan Y; Wu J; Song L; Zhang M; Hipolito CJ; Wu C; Wang S; Zhang Y; Yin Y
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors.
    Milo LJ; Lai JH; Wu W; Liu Y; Maw H; Li Y; Jin Z; Shu Y; Poplawski SE; Wu Y; Sanford DG; Sudmeier JL; Bachovchin WW
    J Med Chem; 2011 Jul; 54(13):4365-77. PubMed ID: 21634429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid phase synthesis of aminoboronic acids: potent inhibitors of the hepatitis C virus NS3 proteinase.
    Dunsdon RM; Greening JR; Jones PS; Jordan S; Wilson FX
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1577-9. PubMed ID: 10915055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy.
    Dick LR; Fleming PE
    Drug Discov Today; 2010 Mar; 15(5-6):243-9. PubMed ID: 20116451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors.
    Watanabe T; Momose I; Abe M; Abe H; Sawa R; Umezawa Y; Ikeda D; Takahashi Y; Akamatsu Y
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2343-5. PubMed ID: 19307118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications.
    Silva MP; Saraiva L; Pinto M; Sousa ME
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32967170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocyclic proteasome inhibitors.
    Krahn D; Ottmann C; Kaiser M
    Curr Med Chem; 2011; 18(33):5052-60. PubMed ID: 22050753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.
    Watanabe T; Abe H; Momose I; Takahashi Y; Ikeda D; Akamatsu Y
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5839-42. PubMed ID: 20727746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells.
    Kazi A; Lawrence H; Guida WC; McLaughlin ML; Springett GM; Berndt N; Yip RM; Sebti SM
    Cell Cycle; 2009 Jun; 8(12):1940-51. PubMed ID: 19471122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates.
    Zhu Y; Zhao X; Zhu X; Wu G; Li Y; Ma Y; Yuan Y; Yang J; Hu Y; Ai L; Gao Q
    J Med Chem; 2009 Jul; 52(14):4192-9. PubMed ID: 19537716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.
    Ge Y; Li A; Wu J; Feng H; Wang L; Liu H; Xu Y; Xu Q; Zhao L; Li Y
    Eur J Med Chem; 2017 Mar; 128():180-191. PubMed ID: 28182990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal bortezomib nanoparticles via boronic ester prodrug formulation for improved therapeutic efficacy in vivo.
    Ashley JD; Stefanick JF; Schroeder VA; Suckow MA; Kiziltepe T; Bilgicer B
    J Med Chem; 2014 Jun; 57(12):5282-92. PubMed ID: 24897555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.
    Momose I; Abe H; Watanabe T; Ohba S; Yamazaki K; Dan S; Yamori T; Masuda T; Nomoto A
    Cancer Sci; 2014 Dec; 105(12):1609-15. PubMed ID: 25251038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα- and αβ-amino acids.
    Shi J; Lei M; Wu W; Feng H; Wang J; Chen S; Zhu Y; Hu S; Liu Z; Jiang C
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1958-62. PubMed ID: 26965867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
    Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF
    Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boronic esters in asymmetric synthesis.
    Matteson DS
    J Org Chem; 2013 Oct; 78(20):10009-23. PubMed ID: 23875690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.
    Zhu Y; Wu G; Zhu X; Ma Y; Zhao X; Li Y; Yuan Y; Yang J; Yu S; Shao F; Lei M
    J Med Chem; 2010 Dec; 53(24):8619-26. PubMed ID: 21077681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the proteasome inhibitor Velcade (Bortezomib).
    Adams J; Kauffman M
    Cancer Invest; 2004; 22(2):304-11. PubMed ID: 15199612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification and synthesis of ubiquitin-proteasome inhibitor].
    Li J; Zhang DY; Wu XM
    Yao Xue Xue Bao; 2009 Dec; 44(12):1313-9. PubMed ID: 21351462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.